Anteris Technologies
Update in progressAVR.AX (ASX)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Anteris Technologies Global Corp is a structural heart company focused on minimally invasive devices for heart valve disease. Its DurAVR transcatheter aortic valve treats severe aortic stenosis and aims to mimic native valve function. ADAPT anti-calcification tissue creates durable bioscaffolds from xenograft tissue for valve repair and other surgeries. ComASUR is a balloon-expanded delivery system with a reinforced steerable catheter for precise, safe navigation of the heart. Based in Toowong, Australia.
Company score
- Sentiment
- 0.48
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.33
- Governance
- 0.13
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.13
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.30
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketASX (ASX)
- LocationAustralia
- CEOMr. Wayne Geoffrey Paterson
- Employees174
- Websiteanteristech.com
Identifiers
- ISINAU0000088841